Profile data is unavailable for this security.
About the company
The Joint Corp. is an operator, manager and franchisor of chiropractic clinics that uses a private pay, non-insurance, cash-based model. The Company operates through two segments: Corporate Clinics and Franchise Operations. The Corporate Clinics segment is comprised of the operating activities of the Company-owned or managed clinics. The Company operates or manages approximately 135 clinics under this segment. The Franchise Operations segment is comprised of the operating activities of the franchise business unit. The franchise system consists of approximately 800 clinics in operation. It offers a range of membership and wellness packages. It offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention. Each patient's records are digitally updated for ready retrieval in its data storage system by its chiropractors in compliance with various applicable medical records security and privacy regulations.
- Revenue in USD (TTM)117.70m
- Net income in USD-9.75m
- Incorporated2010
- Employees444.00
- LocationJoint Corp16767 N PERIMETER DRIVE, SUITE 240SCOTTSDALE 85260United StatesUSA
- Phone+1 (480) 245-5960
- Fax+1 (480) 513-7989
- Websitehttps://www.thejoint.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oncology Institute Inc | 324.24m | -67.88m | 91.40m | 800.00 | -- | 1.60 | -- | 0.2819 | -0.9187 | -0.9187 | 4.39 | 0.7691 | 1.38 | 23.08 | 7.89 | 405,298.80 | -35.28 | -- | -40.88 | -- | 18.37 | 19.54 | -25.62 | -9.99 | 3.73 | -8.16 | 0.6036 | -- | 28.42 | 23.43 | -99,919.12 | -- | 45.68 | -- |
| ProPhase Labs Inc | 44.38m | -16.78m | 98.17m | 113.00 | -- | 1.99 | -- | 2.21 | -0.9544 | -0.9544 | 2.53 | 2.74 | 0.4943 | 7.20 | 1.21 | 392,778.80 | -18.69 | 0.9106 | -23.53 | 1.12 | 36.59 | 50.32 | -37.81 | 0.9325 | 2.10 | -18.06 | 0.1521 | 665.78 | -63.81 | 27.59 | -190.90 | -- | 86.46 | -- |
| Biodesix Inc | 49.09m | -52.15m | 142.03m | 217.00 | -- | 26.27 | -- | 2.89 | -0.6469 | -0.6469 | 0.5979 | 0.0476 | 0.5113 | -- | 7.70 | 226,207.40 | -54.32 | -55.60 | -76.83 | -80.94 | 73.50 | 59.53 | -106.23 | -105.15 | -- | -4.33 | 0.8851 | -- | 28.46 | 19.16 | 20.32 | -- | 106.31 | -- |
| DLH Holdings Corp | 401.00m | 2.07m | 157.11m | 3.20k | 84.31 | 1.49 | 8.06 | 0.3918 | 0.131 | 0.131 | 27.73 | 7.43 | 1.15 | -- | 6.64 | 125,310.90 | 0.5911 | 5.38 | 0.7382 | 7.20 | 20.83 | 20.56 | 0.515 | 3.41 | -- | 1.45 | 0.6158 | 0.00 | -4.88 | 23.05 | -93.73 | -28.16 | -0.903 | -- |
| Longduoduo Co Ltd | 7.27m | 831.39k | 160.23m | -- | 193.13 | -- | 150.73 | 22.05 | 0.0277 | 0.0277 | 0.2421 | -0.0035 | 4.27 | 620.94 | 103.11 | -- | 58.23 | -- | -- | -- | 92.91 | -- | 13.63 | -- | 0.8548 | -- | -- | -- | 17.93 | -- | 99.48 | -- | -- | -- |
| American Oncology Network Inc | 1.28bn | -9.12m | 161.44m | 1.53k | -- | -- | -- | 0.1262 | -1.19 | -1.19 | 145.02 | -10.16 | -- | -- | -- | 838,809.80 | -- | -- | -- | -- | 6.47 | -- | -4.92 | -- | 1.38 | -3.52 | 0.5499 | -- | 11.27 | -- | -- | -- | -- | -- |
| Joint Corp | 117.70m | -9.75m | 176.13m | 444.00 | -- | 7.11 | -- | 1.50 | -0.6614 | -0.6614 | 7.98 | 1.68 | 1.30 | -- | 30.85 | 265,081.90 | -10.80 | 4.32 | -15.75 | 6.05 | 91.04 | 90.28 | -8.29 | 3.68 | -- | 451.96 | 0.0769 | -- | 16.24 | 26.27 | -1,656.09 | -- | 35.09 | -- |
| 23andMe Holding Co. | 247.99m | -521.97m | 244.11m | 769.00 | -- | 0.6467 | -- | 0.9844 | -1.10 | -1.10 | 0.5293 | 0.7817 | 0.3037 | 9.82 | 11.03 | 322,479.80 | -63.93 | -- | -81.01 | -- | 45.30 | -- | -210.48 | -- | 2.04 | -- | 0.00 | -- | 10.15 | -- | -43.30 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| Bandera Partners LLCas of 31 Dec 2023 | 3.94m | 26.65% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 1.00m | 6.79% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 907.39k | 6.14% |
| Skylands Capital LLCas of 31 Dec 2023 | 603.64k | 4.09% |
| Renaissance Technologies LLCas of 31 Dec 2023 | 366.65k | 2.48% |
| D. E. Shaw & Co. LPas of 31 Dec 2023 | 340.81k | 2.31% |
| Goldman Sachs Asset Management LPas of 31 Dec 2023 | 330.75k | 2.24% |
| Geode Capital Management LLCas of 31 Dec 2023 | 309.31k | 2.09% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 285.07k | 1.93% |
| Morgan Stanley & Co. LLCas of 31 Dec 2023 | 196.87k | 1.33% |
